Qiuye Zhang

407 total citations
29 papers, 208 citations indexed

About

Qiuye Zhang is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiuye Zhang has authored 29 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiuye Zhang's work include Nanoplatforms for cancer theranostics (5 papers), Advanced Nanomaterials in Catalysis (4 papers) and Inflammasome and immune disorders (4 papers). Qiuye Zhang is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Advanced Nanomaterials in Catalysis (4 papers) and Inflammasome and immune disorders (4 papers). Qiuye Zhang collaborates with scholars based in China, Australia and United States. Qiuye Zhang's co-authors include Hui Liu, Hong Chang, Yi Lin, Shiyu Lu, Sheng Zhao, Sophia Kathariou, Nattawan Promadej, John B. Luchansky, Charles J. Czuprynski and Nancy G. Faith and has published in prestigious journals such as Chemical Engineering Journal, ACS Applied Materials & Interfaces and Frontiers in Immunology.

In The Last Decade

Qiuye Zhang

27 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuye Zhang China 11 54 53 52 38 29 29 208
Sandeep Srivastava India 9 93 1.7× 34 0.6× 75 1.4× 12 0.3× 10 0.3× 18 315
Zhirui Zhang China 11 138 2.6× 57 1.1× 27 0.5× 45 1.2× 26 0.9× 28 342
Manju Nidagodu Jayakumar United Arab Emirates 11 127 2.4× 50 0.9× 47 0.9× 26 0.7× 39 1.3× 24 321
Mingzhu Song China 9 90 1.7× 105 2.0× 43 0.8× 58 1.5× 31 1.1× 26 279
Wenjun Jiang China 9 156 2.9× 76 1.4× 62 1.2× 30 0.8× 30 1.0× 12 325
Shunlai Shang China 9 80 1.5× 54 1.0× 66 1.3× 17 0.4× 13 0.4× 28 316
Jia-Hua Ding China 9 102 1.9× 68 1.3× 34 0.7× 10 0.3× 24 0.8× 34 274
Nan Yu China 10 144 2.7× 34 0.6× 36 0.7× 74 1.9× 46 1.6× 33 357
Chenbei Li China 8 112 2.1× 48 0.9× 31 0.6× 30 0.8× 38 1.3× 23 265

Countries citing papers authored by Qiuye Zhang

Since Specialization
Citations

This map shows the geographic impact of Qiuye Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuye Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuye Zhang more than expected).

Fields of papers citing papers by Qiuye Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuye Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuye Zhang. The network helps show where Qiuye Zhang may publish in the future.

Co-authorship network of co-authors of Qiuye Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuye Zhang. A scholar is included among the top collaborators of Qiuye Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuye Zhang. Qiuye Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Jingdong, Hong Chang, Yi Lin, et al.. (2025). Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series. Frontiers in Pharmacology. 16. 1646837–1646837.
2.
Duan, Yifan, Wei Zhang, Yi Ouyang, et al.. (2024). Proton Sponge Nanocomposites for Synergistic Tumor Elimination via Autophagy Inhibition-Promoted Cell Apoptosis and Macrophage Repolarization-Enhanced Immune Response. ACS Applied Materials & Interfaces. 16(14). 17285–17299. 10 indexed citations
3.
Wang, Dahai, Jia Liu, Ranran Zhang, et al.. (2024). Eosinophilic granulomatous polyangiitis with central nervous system involvement in children: a case report and literature review. Frontiers in Immunology. 15. 1 indexed citations
4.
Zhang, Qiuye, et al.. (2023). Clinical implications of aberrant PD-1 expression for acute leukemia prognosis. European journal of medical research. 28(1). 383–383. 4 indexed citations
6.
Liu, Jia, Ranran Zhang, Dahai Wang, et al.. (2022). Elucidating the role of circNFIB in myocardial fibrosis alleviation by endogenous sulfur dioxide. BMC Cardiovascular Disorders. 22(1). 492–492. 6 indexed citations
7.
Zhang, Qiuye, Qiang Yang, Chunmei Chen, et al.. (2022). Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy. Colloids and Surfaces B Biointerfaces. 222. 113091–113091. 8 indexed citations
8.
Yang, Qiang, Wei Zhang, Shiyu Lu, et al.. (2022). Biodegradable doxorubicin-loaded ferric phosphate nanosheets for specific tumor elimination through autophagy inhibition-enhanced apoptosis/ferroptosis pathway. Chemical Engineering Journal. 454. 140455–140455. 16 indexed citations
9.
Wang, Dahai, Ranran Zhang, Guohao Zhu, et al.. (2022). Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study. Frontiers in Immunology. 13. 1067721–1067721. 10 indexed citations
10.
Wang, Dahai, et al.. (2021). Clinical Features and Familial Mutations in an Autosomal-Inherited Alport Syndrome Patient With the Presentation of Nephrotic Syndrome. Frontiers in Pediatrics. 9. 678633–678633. 1 indexed citations
11.
Zhang, Qiuye, Jingjing Wang, Shiyu Lu, et al.. (2021). PEGylated copper(II)‐chelated polydopamine nanocomposites for photothermal‐enhanced chemodynamic therapy against tumor cells. Journal of Applied Polymer Science. 138(40). 14 indexed citations
12.
Zhang, Qiuye, et al.. (2019). Effect of 1, 25-dihydroxy vitamin D3 on food allergy in mice. Zhonghua shiyong erke linchuang zazhi. 34(9). 693–697.
13.
Li, Dan, et al.. (2019). NPHS1 Gene Mutations in Children with Focal Segmental Glomerulosclerosis. 4(1). 1–6. 1 indexed citations
14.
Zhang, Jiakui, Qiuye Zhang, Yingwei Li, et al.. (2018). Immune dysregulation in primary immune thrombocytopenia patients. Hematology. 23(8). 510–516. 15 indexed citations
15.
Hu, Jianxia, et al.. (2018). Novel Mutations in the β2 Integrin Gene (ITGB2) in a Moderate Leukocyte Adhesion Defect type 1 Patient.. PubMed. 21(7). 296–301. 3 indexed citations
16.
Chang, Hong, Yi Lin, Haiyan Zhu, et al.. (2015). Association between toll-like receptor 6 expression and auxiliary T cells in the peripheral blood of pediatric patients with allergic purpura. Experimental and Therapeutic Medicine. 10(4). 1536–1540. 11 indexed citations
17.
Chang, Hong, et al.. (2014). Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch-Schönlein purpura nephritis. Experimental and Therapeutic Medicine. 7(6). 1703–1707. 11 indexed citations
18.
Faith, Nancy G., Sophia Kathariou, Ying Cheng, et al.. (2008). The Role of L. monocytogenes Serotype 4b gtc A in Gastrointestinal Listeriosis in A/J Mice. Foodborne Pathogens and Disease. 6(1). 39–48. 20 indexed citations
19.
Mishra, Jayshree, et al.. (2008). Lipopolysaccharide Increases Cell Surface P-glycoprotein That Exhibits Diminished Activity in Intestinal Epithelial Cells. Drug Metabolism and Disposition. 36(10). 2145–2149. 11 indexed citations
20.
Chen, Yongxing, et al.. (2008). [Changes of peripheral blood dendritic cell functions in children with Henoch-Schonlein purpura and in vitro effect of Astragalus membranaceus].. PubMed. 46(9). 708–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026